Home
Medical Imaging
Molecular Imaging
Nuclear Medicine News & Stories

Nuclear Medicine News & Stories

Theranostics for neuroendocrine tumors: A patient’s experience

After receiving the diagnosis of neuroendocrine tumors, Glenda’s oncologist was unable to provide effective treatment options. Considering her disease burden and noting the progression of the tumors that were difficult to surgically remove, Glenda was referred for theranostics treatment.

Theranostics center of excellence: transforming oncology care

Nebraska Cancer Specialists in the midwestern region of the United States serves as a model of excellence in theranostics. While caring for the local community and attracting patients from across the country, the center also operates an extensive clinical trials program.

By Catherine Marcic Joyce

Highlights from the EANM 2024 Annual Congress

The European Association of Nuclear Medicine’s 37th Annual Meeting took place October 19–23, 2024, in Hamburg, Germany.

By Claudette Lew

PET/CT biomarkers enable clinicians to advance Alzheimer’s disease care

With the latest molecular imaging tools and biomarkers to enhance diagnostic accuracy and enable disease-modifying treatments, clinicians are paving the way for Alzheimer's disease care.

By Dr. K. G. Kallur, Noby Varghese, Abhinav Shanker, Ramya Rajaram

India’s increasing patient population benefits from operational excellence

An oncology team in Bengaluru, India, explains how they maximize their PET/CT scanner’s capabilities to better serve their increasing oncology patient population.

By Sameh Fahmy

Community imaging center once again leads the way with high-performance PET/CT

Situated near the foothills of the Appalachian Mountains, the Rome Imaging Center in Rome, Georgia, USA, is the first site to install the new Biograph Trinion™ PET/CT scanner. This is not the first time this small imaging center in a rural community has been at the forefront of molecular imaging. The center continues to deliver high-quality imaging, all while upholding minimal radiation exposure levels and scan times.

By Claudette Lew

Advancing pediatric molecular imaging

When it comes to molecular imaging in pediatrics, one must remember that children are not simply small adults. Rigshospitalet in Denmark uses a PET/CT scanner that provides ultra-fast scan times and low-dose accommodations for young patients, often eliminating the need for sedation.

By Reinaldo Lopes

Software’s toolbox increases access to care and operational agility

In many countries, the best clinical expertise is often concentrated in and around capitals. Dr. Horacio Amaral, from Santiago, Chile’s capital city, not only has the latest molecular imaging equipment but highly educated users as well. Across this large country, it is important for clinicians to share their expertise, reach more patients, and enable easier access to care in remote parts of Chile. How can they achieve that?

By Catherine Marcic Joyce

EANM’s 2023 Annual Congress highlights

Located along the banks of the Danube River, the capital city of Vienna, Austria, hosted global nuclear medicine experts at EANM’s 36th Annual Congress.

By Philipp Grätzel von Grätz

The wisdom of water

Occasionally, technological progress opens the door for completely new realms of research. Such is the case at Turku PET Centre in Finland, where the Biograph Vision Quadra™ PET/CT is being used for total-body perfusion imaging — something that was simply not possible before.

By Claudette Lew

Growing theranostics program is now everyday clinical practice in Finland

As a true pioneer in the frontier in cancer treatment, The Comprehensive Cancer Center in Helsinki offers precision therapy personalized to the needs of each individual patient.

Catherine Marcic Joyce

SNMMI 2023 Annual Meeting highlights

The SNMMI 2023 Annual Meeting welcomed nuclear medicine and molecular imaging experts from around the world to participate in a multitude of scientific, educational, and networking opportunities.

By Sameh Fahmy

A patient’s experience: Theranostics offers personalized care for prostate cancer

Enabled by molecular imaging technology, theranostics using a PSMA targeted radioligand therapeutic agent has the potential to enhance and prolong life for prostate cancer patients such as John. “I was able to feel more of myself. It was remarkable,“ he says.

By Sameh Fahmy

A physician’s experience: Theranostics offers personalized care for prostate cancer

Professor Joseph R. Osborne, MD, PhD, chief of Molecular Imaging and therapeutics, and professor of radiology at a leading academic institution’s hospital in New York City, NY, USA, discusses theranostics and its rapidly expanding role in prostate cancer care.

By Reinaldo Lopes

Brazil and Argentina meet expanding patient needs with fast, low-dose PET/CT imaging

Doctors in São Paulo, Brazil, and Buenos Aires, Argentina, discovered upgrading their PET/CT scanners enabled them to respond effectively to new patient demands and relieve scheduling pressures, and surpassed expectations by exploring new areas of care.

Services & Support

Education & Training